Binding of quinine- and quinidine-dependent drug antibodies to platelets is mediated by the Fab domain of the...

Area of Science:

• Immunology
• Hematology
• Pharmacology

Background:

• Drug-dependent antibodies cause thrombocytopenia by binding to platelets.
• Cinchona alkaloids are known inducers of drug-dependent thrombocytopenia.
• Understanding the specific antibody domains involved is crucial for diagnosis and treatment.

Purpose of the Study:

• To identify the specific antibody domain responsible for binding to platelet membranes in drug-dependent (dd) antibody-mediated thrombocytopenia.
• To elucidate the mechanism of interaction between dd antibodies and platelets induced by cinchona alkaloids.

Main Methods:

• Purified drug-dependent immunoglobulin G (dd-IgG) was fragmented into F(ab')2, Fab, and Fc components.
• Direct binding radioimmunoassay (RIA) was used to quantify antibody binding to platelet membranes.
• Competition assays (RIA and complement fixation) were performed to assess the binding capacity of antibody fragments versus intact IgG.

Main Results:

• F(ab')2 and Fab fragments demonstrated drug-dependent binding to platelet membranes, while Fc fragments did not.
• Both F(ab')2 and Fab fragments competed with intact IgG for binding sites on platelet membranes.
• Fc fragments showed no competition, indicating they do not mediate attachment.

Conclusions:

• The Fab domain of drug-dependent antibodies is responsible for their attachment to the platelet surface.
• This finding clarifies the molecular mechanism underlying drug-induced thrombocytopenia.
• The results provide a basis for further investigation into antibody-mediated platelet destruction.